Speaker
Director, Oncology Search & Evaluation, Business Development & Licensing, Merck & Co
Carla Bauer, Director, Oncology Search & Evaluation, Business Development & Licensing at Merck & Co, appears in the programmes of 2 conferences on kongre.net. Most recently: 9th TPD & Induced Proximity Summit (Boston, United States of America, 26–29 Oct 2026).
26–29 Oct 2026Boston, United States of America
9–10 Sept 2026Boston, United States of America
Professor, Harvard Medical School
President & Chief Executive Officer, Arvinas, Inc.
Associate Director, Medicinal Chemistry, AstraZeneca
Co-Founder & Chief Technology Officer, Sibylla Biotech srl
Chief Executive Officer, Trimtech Therapeutics
Assistant Professor, University of California, Irvine
Search & Evaluation Lead, GI & Inflammation, Strategy & Portfolio Development, Takeda Pharmaceutical
Head of Search and Evaluation - Respiratory and Immunology, AstraZeneca
Co-Founder & Chief Technology Officer, Sibylla Biotech srl
Chief Executive Officer, Synthis Therapeutics
Chief Executive Officer, Trimtech Therapeutics
Director - Strategic Research & Development, Otsuka America Pharmaceutical, Inc
This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Carla Bauer, and it lists only the talks, sessions and presentations named in those programmes.
Is this you? Claim this profile — every request is read by a person before anything is linked.
To ask for a correction or for this profile to be removed, email [email protected].